Relmada Therapeutics names Bipin Dalmia chief business officer

• Relmada named Bipin Dalmia as chief business officer, leading corporate strategy, commercial planning, business development; reporting to CEO Sergio Traversa.
• Dalmia brings nearly three decades in biopharma leadership, spanning NMIBC, corporate strategy, business development.
• Appointment aligns with NDV-01 program as Relmada moves toward late-stage development for its sustained-release intravesical NMIBC therapy.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Relmada Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607280830PRIMZONEFULLFEED9798974) on July 28, 2026, and is solely responsible for the information contained therein.